Artax Biopharma
Cambridge, United States· Est. 2015
Discover Artax Biopharma's pioneering Nck modulators that restore immune balance without immunosuppression. Learn more about our clinical advancements.
Private Company
Total funding raised: $120M
About
Discover Artax Biopharma's pioneering Nck modulators that restore immune balance without immunosuppression. Learn more about our clinical advancements.
Small Molecules
Funding History
2Total raised:$120M
Series B$85MMar 15, 2023
Series A$35MJun 15, 2021